Clinical Trial Update: Oxytocin Dosing at Planned Cesarean Section and Anemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating oxytocin dosing during planned cesarean section was withdrawn, with relevance to anemia from blood loss and uterine atony with hemorr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Postpartum Hemorrhage
• Uterine Atony

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Blood Loss Anemia, Uterine Atony With Hemorrhage | Phase 4 | Status: WITHDRAWN